| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 215 |
| 1 | ADALIMUMAB | 85 |
| 2 | IBUPROFEN | 82 |
| 3 | IBUPFROFEN | 78 |
| 4 | IBUPROFEN 200 MG | 78 |
| 5 | IBUPROFEN 200MG | 78 |
| 6 | IBUPROFEN CAPSULE | 78 |
| 7 | IBUPROFEN CAPSULES 200 MG | 78 |
| 8 | IBUPROFEN ORAL | 78 |
| 9 | IBUPROFEN TABLET, FILM COATED | 78 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSAMPRENAVIR CALCIUM | 26 | 0.1985 |
| 1 | FRANKINCENSE | 4 | 0.0656 |
| 2 | HEXAMINOLEVULINATE HYDROCHLORIDE | 1 | 0.0227 |
| 3 | GEMCITABINE INTRAVESICAL | 10 | 0.0207 |
| 4 | BACILLUS CALMETTE-GUERIN | 16 | 0.0090 |
| 5 | VALRUBICIN | 1 | 0.0056 |
| 6 | PIVMECILLINAM | 1 | 0.0053 |
| 7 | XYLOMETAZOLINE HYDROCHLORIDE | 3 | 0.0053 |
| 8 | RALTEGRAVIR | 26 | 0.0050 |
| 9 | DANTROLENE SODIUM | 5 | 0.0044 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 272 |
| 1 | Corticosteroid [EPC] | 216 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 188 |
| 3 | Proton Pump Inhibitor [EPC] | 66 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 64 |
| 5 | Vitamin C [EPC] | 60 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 58 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 58 |
| 8 | Alkylating Drug [EPC] | 56 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 48 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 16 | 0.0090 |
| 1 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 2 | Actinomycin [EPC] | 5 | 0.0023 |
| 3 | Provitamin D2 Compound [EPC] | 45 | 0.0015 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 27 | 0.0011 |
| 5 | Nitrofuran Antibacterial [EPC] | 18 | 0.0010 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 272 | 0.0009 |
| 8 | Human Immunoglobulin G [EPC] | 14 | 0.0007 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 58 | 0.0006 |